From the Journals

Diabetes, Amyloid-β Interaction Doubles MCI Risk

Managing diabetes may reduce Alzheimer’s risk, as 20-year data reveal synergistic brain changes from diabetes and amyloid-β abnormality.

Share

A longitudinal study tracking 185 middle-aged and older adults identified accelerated brain atrophy and abnormal amyloid-β ratios as significant risk factors for cognitive decline, especially when combined with type 2 diabetes. The study revealed profound insights into brain structure changes that precede cognitive deterioration and stressed the importance of improved imaging methods for consistent long-term use.

Original Source(s)

Diabetes, Amyloid-β Interaction Doubles MCI Risk

Managing diabetes may reduce Alzheimer’s risk, as 20-year data reveal synergistic brain changes from diabetes and amyloid-β abnormality.

  • by Kerri Miller

  • November 18, 2024

  • 2 min

Related Content

Blood Tau Trajectories Tied to Alzheimer's Onset

Repeated blood tau measurements were associated with age at symptom onset among individuals at risk for Alzheimer's disease 

Medical Oddities: For the Birds—and the Brain

Birds for brains, blackout laughs, anti-aging tea, thin air, muscle memory—and torn marriages, all with a clinical touch this week.

How Midlife Diet Relates to Cognitive Aging 

Healthier dietary patterns were associated with better later-life cognitive outcomes